Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals GTN rebate accruals — Beginning balance by Year
GTN rebate accruals — Beginning balance ($M) ($M)
Vertex Pharmaceuticals GTN rebate accruals — Beginning balance: $1,607M in FY2025, down 5.6% from a year earlier.
Where the FY2025 figure comes from
“|| Balance at December 31, 2024 | $ 1,607.1”
Source: Form 10-K (vrtx-20251231.htm, filed 2026-02-13) ↗
Reported in Form 10-K MD&A (Critical Accounting Policies — Gross-to-Net Rebate Rollforward).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Vertex Pharmaceuticals GTN rebate accruals — Beginning balance ($M), annual FY2013–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/gtn-beg-bal
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.